193 related articles for article (PubMed ID: 31188431)
1. Central Hypothyroidism Related to Pituitary Adenomas: Low Incidence of Central Hypothyroidism in Patients With Acromegaly.
Takamizawa T; Horiguchi K; Nakajima Y; Okamura T; Ishida E; Matsumoto S; Yoshino S; Yamada E; Saitoh T; Ozawa A; Tosaka M; Yamada S; Yamada M
J Clin Endocrinol Metab; 2019 Oct; 104(10):4879-4888. PubMed ID: 31188431
[TBL] [Abstract][Full Text] [Related]
2. The Effect and Potential Mechanism Analysis of Growth Hormone-Secreting Pituitary Adenomas on Thyroid Function.
Mo C; Chen H; Guo Y; Li Z; Wang Y; Zhong L
Endocr Pract; 2023 Jul; 29(7):546-552. PubMed ID: 37217118
[TBL] [Abstract][Full Text] [Related]
3. Goiter and impairment of thyroid function in acromegalic patients: basal evaluation and follow-up.
Cannavò S; Squadrito S; Finocchiaro MD; Curtò L; Almoto B; Vieni A; Trimarchi F
Horm Metab Res; 2000 May; 32(5):190-5. PubMed ID: 10871160
[TBL] [Abstract][Full Text] [Related]
4. Acromegaly without imaging evidence of pituitary adenoma.
Lonser RR; Kindzelski BA; Mehta GU; Jane JA; Oldfield EH
J Clin Endocrinol Metab; 2010 Sep; 95(9):4192-6. PubMed ID: 20610592
[TBL] [Abstract][Full Text] [Related]
5. The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011.
Tjörnstrand A; Gunnarsson K; Evert M; Holmberg E; Ragnarsson O; Rosén T; Filipsson Nyström H
Eur J Endocrinol; 2014 Oct; 171(4):519-26. PubMed ID: 25084775
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of Gut Microbiota in Patients with GH-Secreting Pituitary Adenoma.
Lin B; Wang M; Gao R; Ye Z; Yu Y; He W; Qiao N; Ma Z; Ji C; Shi C; Zhou X; Wang Y; Zeng F; Zhang L; Gong W; Cao Z; Zhou P; Melnikov V; Ye H; Li Y; Zhang Z; He M; Qin H; Zhang Y
Microbiol Spectr; 2022 Feb; 10(1):e0042521. PubMed ID: 35019688
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of acromegaly in Ecuador.
López Gavilanez E; Guerrero Franco K; Solórzano Zambrano N; Navarro Chávez M; López Estrella C; Vaca Burbano L; Marriott Díaz E
Endocrinol Nutr; 2016; 63(7):333-8. PubMed ID: 27158065
[TBL] [Abstract][Full Text] [Related]
8. Uric acid levels correlate with disease activity in growth hormone-secreting pituitary adenoma patients.
Mo C; Chen H; Wang F; Guo Y; Wang Y; Tong T; Zhong L
Front Endocrinol (Lausanne); 2023; 14():1230852. PubMed ID: 37818085
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and complications of neurosurgical treatment of acromegaly.
Krzentowska-Korek A; Gołkowski F; Bałdys-Waligórska A; Hubalewska-Dydejczyk A
Pituitary; 2011 Jun; 14(2):157-62. PubMed ID: 21107739
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics and Associated Factors of Colonic Polyps in Acromegaly.
Peng G; Li X; Zhou Y; Bai J; Hong P; Li W; Zhang Y; Zhang L; Liao Q; Liao M; Zhou L; Sun Z; Shen R; Zheng H; Long M
Exp Clin Endocrinol Diabetes; 2022 Nov; 130(11):714-722. PubMed ID: 36075228
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of TSH-secreting pituitary adenoma and autoimmune hypothyroidism.
Losa M; Mortini P; Minelli R; Giovanelli M
J Endocrinol Invest; 2006 Jun; 29(6):555-9. PubMed ID: 16840835
[TBL] [Abstract][Full Text] [Related]
12. Differentiated thyroid carcinoma in sporadic and familial presentations of acromegaly: A case series.
Rogozinski A; Daly AF; Reyes A; Furioso A; Beckers A; Lowenstein A
Ann Endocrinol (Paris); 2020 Oct; 81(5):482-486. PubMed ID: 32822652
[TBL] [Abstract][Full Text] [Related]
13. "Micromegaly": an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era.
Butz LB; Sullivan SE; Chandler WF; Barkan AL
Pituitary; 2016 Dec; 19(6):547-551. PubMed ID: 27497970
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of acromegaly in hospitalized patients with type 2 diabetes.
Suda K; Fukuoka H; Iguchi G; Hirota Y; Nishizawa H; Bando H; Matsumoto R; Takahashi M; Sakaguchi K; Takahashi Y
Endocr J; 2015; 62(1):53-9. PubMed ID: 25284247
[TBL] [Abstract][Full Text] [Related]
15. BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma.
Shi C; Ye Z; Han J; Ye X; Lu W; Ji C; Li Z; Ma Z; Zhang Q; Zhang Y; He W; Chen Z; Cao X; Shou X; Zhou X; Wang Y; Zhang Z; Li Y; Ye H; He M; Chen H; Cheng H; Sun J; Cai J; Huang C; Ye F; Luo C; Zhou B; Ding H; Zhao Y
Neuro Oncol; 2020 Aug; 22(8):1114-1125. PubMed ID: 32246150
[TBL] [Abstract][Full Text] [Related]
16. The higher incidence of autoimmune thyroid disease in prolactinomas than in somatotrophinomas.
Dogansen SC; Selcukbiricik OS; Bilir BE; Yarman S
Growth Horm IGF Res; 2016 Aug; 29():45-49. PubMed ID: 27105040
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
18. 'Silent' somatotropinoma.
Pawlikowski M; Kuta J; Fuss-Chmielewska J; Winczyk K
Endokrynol Pol; 2012; 63(2):88-91. PubMed ID: 22538745
[TBL] [Abstract][Full Text] [Related]
19. Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis.
Jahangiri A; Wagner JR; Han SW; Tran MT; Miller LM; Chen R; Tom MW; Ostling LR; Kunwar S; Blevins L; Aghi MK
J Neurosurg; 2016 Mar; 124(3):589-95. PubMed ID: 26252454
[TBL] [Abstract][Full Text] [Related]
20. Elevation of growth hormone secretagogue receptor type 1a mRNA expression in human growth hormone-secreting pituitary adenoma harboring G protein alpha subunit mutation.
Xu T; Ye F; Wang B; Tian C; Wang S; Shu K; Guo D; Lei T
Neuro Endocrinol Lett; 2010; 31(1):147-54. PubMed ID: 20150876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
